204 related articles for article (PubMed ID: 34375684)
1. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
[TBL] [Abstract][Full Text] [Related]
2. Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
Yu F; Xue Y; Zhao Y; Zhang L; He X; Liu Z
Gynecol Endocrinol; 2023 Dec; 39(1):2183045. PubMed ID: 36842967
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model.
He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W
Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of Kuntai Capsules in treatment of polycystic ovary syndrome rat models based on AGE-RAGE signal pathway].
Huang JG; Zhang J; Xiang RJ; Wu YY; He TY; Zhao MN; Wang F
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1082-1090. PubMed ID: 38621915
[TBL] [Abstract][Full Text] [Related]
5. Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats.
Xing C; Lv B; Zhao H; Wang D; Li X; He B
J Steroid Biochem Mol Biol; 2021 Nov; 214():105992. PubMed ID: 34478829
[TBL] [Abstract][Full Text] [Related]
6. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet.
Peng MF; Tian S; Song YG; Li CX; Miao MS; Ren Z; Li M
J Ethnopharmacol; 2021 Jun; 273():113947. PubMed ID: 33617969
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance.
Morishita M; Endo T; Baba T; Kuno Y; Ikeda K; Kiya T; Honnma H; Saito T
J Ovarian Res; 2018 Mar; 11(1):24. PubMed ID: 29580285
[TBL] [Abstract][Full Text] [Related]
8. [Effects of berberine on LPS /NF-κB and MAPK signaling pathways in PCOS model rats].
Zhao FQ; Zhao Y; Liu JY; Gou YJ; Yang YQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Mar; 38(2):181-186. PubMed ID: 36031579
[No Abstract] [Full Text] [Related]
9. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
10. Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat.
Hu T; Yuan X; Ye R; Zhou H; Lin J; Zhang C; Zhang H; Wei G; Dong M; Huang Y; Lim W; Liu Q; Lee HJ; Jin W
J Nutr Biochem; 2017 Sep; 47():21-28. PubMed ID: 28501702
[TBL] [Abstract][Full Text] [Related]
11. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
12. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.
Mahmoud AA; Elfiky AM; Abo-Zeid FS
Steroids; 2022 Jan; 177():108936. PubMed ID: 34752810
[TBL] [Abstract][Full Text] [Related]
13. Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats.
Misugi T; Ozaki K; El Beltagy K; Tokuyama O; Honda K; Ishiko O
Gynecol Obstet Invest; 2006; 61(4):208-15. PubMed ID: 16479139
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
[TBL] [Abstract][Full Text] [Related]
15. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats.
Jang M; Lee MJ; Lee JM; Bae CS; Kim SH; Ryu JH; Cho IH
PLoS One; 2014; 9(2):e87623. PubMed ID: 24520334
[TBL] [Abstract][Full Text] [Related]
16. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome.
Shah KN; Patel SS
Pharm Biol; 2016; 54(6):975-83. PubMed ID: 26459667
[TBL] [Abstract][Full Text] [Related]
18. MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.
Zhou DN; Li SJ; Ding JL; Yin TL; Yang J; Ye H
Curr Med Sci; 2018 Oct; 38(5):853-860. PubMed ID: 30341520
[TBL] [Abstract][Full Text] [Related]
19. Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone synthesizing enzymes.
Huang Y; Li W; Wang CC; Wu X; Zheng J
Fertil Steril; 2014 Aug; 102(2):589-596.e4. PubMed ID: 24973798
[TBL] [Abstract][Full Text] [Related]
20. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
